GO:0004482 mRNA 5'-cap (guanine-N7-)-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004482 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to the N7 position of the guanine cap on mRNA, forming m7G(5')pppR-RNA.
• This activity is essential for mRNA stability, nuclear export, and efficient translation initiation.
• The enzyme is conserved from yeast to humans; the yeast mRNA cap methyltransferase is a 50-kDa protein encoded by an essential gene.
• Viral pathogens such as West Nile virus and coronaviruses encode their own guanine-N7 methyltransferases to cap viral RNA and evade host innate immunity.
• High-throughput screening assays have been developed to identify inhibitors of mRNA cap guanine-N7 methyltransferase, targeting both host and viral enzymes.
• Dysregulation of cap methylation is linked to cancer, viral replication, and developmental defects, making it a therapeutic target.
Description
The addition of a 7-methylguanosine (m7G) cap to the 5' end of mRNA is a critical post-transcriptional modification that influences nearly every aspect of mRNA metabolism, including stability, splicing, nuclear export, and translation initiation. The enzyme responsible for this modification, mRNA 5'-cap (guanine-N7-)-methyltransferase (RNMT in humans), catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to the N7 position of the guanine nucleotide at the cap structure. This activity is encoded by GO:0004482 and is conserved across eukaryotes, from yeast to humans. In yeast, the enzyme is a 50-kDa protein encoded by an essential gene, underscoring its fundamental role in cell viability. In humans, the enzyme is known as RNMT (RNA guanine-7 methyltransferase), and its activity is required for proper gene expression. Beyond cellular mRNA, many viruses, including West Nile virus and coronaviruses, encode their own guanine-N7 methyltransferases to cap viral RNA, which helps them evade host immune detection. The essential nature of this activity and its role in viral pathogenesis have made it an attractive target for antiviral and anticancer drug development. Researchers studying GO:0004482 are interested in understanding its catalytic mechanism, its regulation, and its potential as a therapeutic target. This article provides a comprehensive overview of the molecular function, key genes, disease associations, and research methods relevant to mRNA 5'-cap (guanine-N7-)-methyltransferase activity.
mRNA 5'-cap (guanine-N7-)-methyltransferase activity At A Glance
| GO ID | GO:0004482 |
|---|---|
| GO term | mRNA 5'-cap (guanine-N7-)-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | guanine-7-methyltransferase activity; messenger ribonucleate guanine 7-methyltransferase activity; messenger RNA guanine 7-methyltransferase activity; S-adenosyl-L-methionine:mRNA (guanine-7-N-)-methyltransferase activity; S-adenosyl-L-methionine:mRNA (guanine-N7-)-methyltransferase activity |
| Major function | Catalyzes the methylation of the N7 position of the guanine cap on mRNA, forming m7G(5')pppR-RNA |
| Substrate | S-adenosyl-L-methionine and G(5')pppR-RNA |
| Product | S-adenosyl-L-homocysteine and m7G(5')pppR-RNA |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Cellular location | Nucleus (for host enzymes); viral enzymes may localize to cytoplasm |
What Is GO:0004482?
GO:0004482, mRNA 5'-cap (guanine-N7-)-methyltransferase activity, is a molecular function defined by the catalysis of the reaction: S-adenosyl-L-methionine + G(5')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5')pppR-RNA. In this reaction, a methyl group is transferred from S-adenosyl-L-methionine to the N7 position of the guanine nucleotide at the 5' cap of mRNA, resulting in the formation of N7-methylguanine cap (m7G(5')pppR-RNA). The substrate RNA contains a 5' cap with a guanosine or adenosine at the R position. This activity is synonymous with guanine-7-methyltransferase activity, messenger ribonucleate guanine 7-methyltransferase activity, and S-adenosyl-L-methionine:mRNA (guanine-N7-)-methyltransferase activity.
Why Is mRNA 5'-cap (guanine-N7-)-methyltransferase activity Important in Cell Biology?
The mRNA 5'-cap guanine-N7 methyltransferase activity is essential for the proper functioning of mRNA in eukaryotic cells. The m7G cap protects mRNA from 5' exonucleases, facilitates nuclear export, and is recognized by the translation initiation factor eIF4E to promote protein synthesis. In yeast, the enzyme is encoded by an essential gene, and its deletion is lethal. In humans, the enzyme RNMT is critical for cell proliferation and survival. Furthermore, many viruses, including West Nile virus and coronaviruses, encode their own guanine-N7 methyltransferases to cap viral RNA, which is a key step in evading the host's innate immune response. The activity is also a target for antiviral and anticancer therapies, as inhibiting it can block viral replication and cancer cell growth. Therefore, understanding GO:0004482 is important for basic biology, virology, and drug discovery.
• Essential for mRNA stability and protection from 5' exonucleases.
• Required for efficient translation initiation via recognition by eIF4E.
• Critical for nuclear export of mRNA.
• Viral guanine-N7 methyltransferases are virulence factors that help evade host immunity.
• Inhibition of the activity is a potential antiviral strategy against coronaviruses and flaviviruses.
• Dysregulation is associated with cancer and developmental disorders.
• Target for high-throughput screening to identify small-molecule inhibitors.
• Conserved from yeast to humans, making yeast a useful model organism.
• Plays a role in mRNA recapping in trypanosomes.
• Photo-controlled variants enable precise spatiotemporal regulation of activity.
What Happens During mRNA 5'-cap (guanine-N7-)-methyltransferase activity?
Substrate Recognition and Binding
In simple terms: The enzyme first grabs the mRNA cap and the methyl donor molecule.
The enzyme recognizes the 5' cap structure of mRNA, which consists of a guanosine nucleotide linked via a 5'-5' triphosphate bond to the first transcribed nucleotide (G(5')pppR-RNA). It also binds the methyl donor S-adenosyl-L-methionine (SAM). The binding of these substrates positions them for catalysis. In yeast, the mRNA cap methyltransferase is a 50-kDa protein that specifically binds the cap structure.
Methyl Group Transfer
In simple terms: The enzyme moves a methyl group from SAM onto the cap guanine.
The catalytic step involves the transfer of a methyl group from S-adenosyl-L-methionine to the N7 position of the guanine base in the cap structure. This results in the formation of m7G(5')pppR-RNA and S-adenosyl-L-homocysteine. The reaction is essential for creating the mature cap that is recognized by cellular machinery.
Product Release and Recycling
In simple terms: After the reaction, the methylated mRNA and byproduct are released.
Following methylation, the m7G-capped mRNA is released to participate in downstream processes such as splicing, export, and translation. The byproduct S-adenosyl-L-homocysteine is released and can be recycled. The enzyme is then free to catalyze another round of methylation.
Viral Cap Methylation
In simple terms: Viruses use their own version of this enzyme to cap their RNA and hide from the immune system.
Many viruses, such as West Nile virus and coronaviruses, encode their own guanine-N7 methyltransferases. For example, West Nile virus nonstructural protein 5 (NS5) sequentially methylates the guanine N-7 and ribose 2'-O positions to form the viral cap. This viral capping mimics host mRNA, helping the virus evade detection by the innate immune system.
Regulation by Hypermethylation
In simple terms: In some organisms, extra methylation can trigger recapping.
In Trypanosoma brucei, mRNA recapping is triggered by hypermethylation originating from cap 4, which involves the guanine-N7 methyltransferase activity. This demonstrates additional regulatory layers in protozoan parasites.
Key Genes Involved in GO:0004482 mRNA 5'-cap (guanine-N7-)-methyltransferase activity
The following genes and proteins are key players in mRNA 5'-cap (guanine-N7-)-methyltransferase activity across different organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNMT (human) | Catalyzes guanine-N7 methylation of mRNA cap | Target for anticancer and antiviral research |
| RAM (human) | Regulatory subunit of RNMT, stimulates activity | Modulates RNMT function; potential drug target |
| Abd1 (yeast) | Essential mRNA cap methyltransferase | Model for studying essential gene function |
| Candida albicans mRNA cap methyltransferase | Fungal cap methylation | Antifungal target; residues essential for catalysis identified |
| West Nile virus NS5 | Viral guanine-N7 and 2'-O methyltransferase | Viral evasion of immunity; antiviral target |
| Coronavirus nsp14 | Viral guanine-N7 methyltransferase | Inhibitor screening; antiviral development |
| African swine fever virus EP424R | 2'-O-methyltransferase (not N7) | Viral replication; distinct from N7 but related |
| Trypanosoma brucei cap methyltransferase | mRNA recapping triggered by hypermethylation | Parasite biology; drug target |
| Vaccinia virus VP39 | Viral cap methyltransferase | Model for viral capping |
| Human RNMT-RAM complex | Holoenzyme for cap methylation | Structural and functional studies |
| Yeast Abd1p | 50-kDa essential protein | Biochemical assays |
| Candida albicans Cgt1 | Cap methyltransferase | Antifungal target |
| Photo-controlled RNMT variant | Light-regulated activity | Optogenetic control of mRNA capping |
| Coronavirus nsp14-nsp10 complex | Viral methyltransferase complex | Screening for inhibitors |
| West Nile virus NS5 methyltransferase domain | Sequential N7 and 2'-O methylation | Antiviral target |
| Trypanosome cap 4 methyltransferase | Hypermethylation and recapping | Parasite-specific recapping |
How Is mRNA 5'-cap (guanine-N7-)-methyltransferase activity Regulated?
The activity of mRNA 5'-cap guanine-N7 methyltransferase is regulated at multiple levels. In humans, the enzyme RNMT forms a complex with its regulatory subunit RAM, which stimulates methyltransferase activity. The expression of RNMT can be regulated by growth factors and oncogenic signaling pathways, linking cap methylation to cell proliferation. In yeast, the essential gene ABD1 encodes the methyltransferase, and its activity is required for cell viability. Viral enzymes, such as coronavirus nsp14, are regulated by interactions with other viral proteins like nsp10, which enhances their methyltransferase activity. Additionally, in Trypanosoma brucei, recapping is triggered by hypermethylation originating from cap 4, indicating a regulatory mechanism that responds to specific developmental or environmental cues. Photo-controlled variants have been engineered to regulate activity with light, providing a tool for precise spatiotemporal control.
mRNA 5'-cap (guanine-N7-)-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNMT | Cancer; cell proliferation | Knockout and overexpression in cancer cell lines |
| West Nile virus NS5 | Viral evasion of immunity | Infection models with methyltransferase mutants |
| Coronavirus nsp14 | Viral replication and immune evasion | Yeast-based assays for inhibitor screening |
| Trypanosoma brucei cap methyltransferase | Parasite recapping | Parasite knockout and recapping assays |
| Candida albicans cap methyltransferase | Fungal pathogenesis | Yeast-based assays and mutagenesis |
Cancer
Dysregulation of mRNA cap methylation is implicated in cancer. The human RNMT-RAM complex is essential for cell proliferation, and its overexpression or hyperactivation can promote oncogenic transformation by enhancing the translation of growth-promoting mRNAs. Targeting RNMT activity with small-molecule inhibitors is being explored as a therapeutic strategy for cancer.
Viral Infections
Many viruses, including coronaviruses and flaviviruses, rely on their own guanine-N7 methyltransferases to cap viral RNA and evade host innate immunity. For example, West Nile virus NS5 methylates the viral cap to mimic host mRNA, preventing detection by interferon-induced proteins. Inhibitors of viral methyltransferases are potential antiviral drugs.
Parasitic Diseases
In Trypanosoma brucei, mRNA recapping triggered by hypermethylation is important for parasite survival and adaptation. The cap 4 structure and recapping process are potential targets for antiparasitic drugs.
Developmental Disorders
Given the essential role of cap methylation in gene expression, mutations in the enzymes could lead to developmental defects. However, specific human diseases linked to RNMT mutations are not well characterized, and further research is needed.
From mRNA 5'-cap (guanine-N7-)-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the gene essential for cell viability? | CRISPR knockout in human cell lines |
| What is the catalytic mechanism? | Point mutations in catalytic residues |
| How does the enzyme interact with regulatory subunits? | Knock-in of tagged enzyme for proteomics |
| Can we control activity with light? | Photo-controlled knock-in variants |
| What is the effect of overexpression? | Overexpression cell models |
| Can we screen for inhibitors? | High-throughput screening assays |
How to Study the mRNA 5'-cap (guanine-N7-)-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| High-throughput screening assay | Methyltransferase activity | Inhibitor discovery |
| Yeast-based assay | Viral methyltransferase inhibition | Antiviral screening |
| Biochemical assay | Kinetic parameters | Mechanistic studies |
| Mutagenesis | Essential catalytic residues | Structure-function analysis |
| Computational design | Photo-controlled variants | Optogenetic tool development |
| RNA-seq | Gene expression changes | Functional consequences |
| Proteomics | Protein interactions | Complex composition |
High-Throughput Screening Assays
Direct high-throughput screening assays have been developed to measure mRNA cap guanine-N7 methyltransferase activity. These assays use fluorescent or radioactive substrates to monitor the methylation reaction and are suitable for identifying small-molecule inhibitors. Yeast-based assays have also been developed for screening inhibitors of coronavirus RNA cap guanine-N7 methyltransferase.
Biochemical and Structural Studies
Biochemical assays using purified enzymes, such as the yeast 50-kDa methyltransferase, allow detailed kinetic and mechanistic studies. Mutational analysis has identified residues essential for catalysis in Candida albicans. Structural studies of viral enzymes like West Nile virus NS5 provide insights into substrate binding and catalysis.
Computational Design and Optogenetics
Computational design has been used to engineer photo-controlled variants of mRNA-cap guanine-N7 methyltransferase, enabling light-regulated activity. This approach combines molecular modeling with experimental characterization to create novel tools for studying cap methylation with spatiotemporal precision.
RNA Sequencing and Proteomics
RNA sequencing can assess the impact of cap methylation on gene expression, splicing, and stability. Proteomics can identify interacting partners and post-translational modifications of the methyltransferase. These methods are useful for understanding the broader cellular consequences of altered cap methylation.
How CRISPR Can Be Used to Study GO:0004482 mRNA 5'-cap (guanine-N7-)-methyltransferase activity
Knockout
CRISPR knockout of the gene encoding mRNA 5'-cap guanine-N7 methyltransferase (e.g., RNMT in human cells or ABD1 in yeast) can be used to study its essentiality. In yeast, ABD1 is essential, and knockout is lethal. In human cells, knockout of RNMT reduces cell proliferation and alters gene expression.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in catalytic residues to dissect the mechanism. For example, residues essential for catalysis in Candida albicans were identified by mutagenesis. Point mutations can also be used to create separation-of-function alleles.
Knock-in
CRISPR knock-in can be used to tag the endogenous enzyme with fluorescent or affinity tags for imaging and proteomics. Knock-in of photo-controlled variants allows light-regulated activity. Tagged knock-in models are valuable for studying localization and interactions.
Overexpression
CRISPR overexpression (e.g., via CRISPRa) can increase the levels of the methyltransferase to study the effects of hypermethylation on mRNA metabolism and cell behavior. Overexpression of RNMT may promote oncogenic transformation.
How EDITGENE Supports mRNA 5'-cap (guanine-N7-)-methyltransferase activity Research
Researchers studying mRNA 5'-cap (guanine-N7-)-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in mRNA capping, viral replication, or cancer cell proliferation. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for mRNA 5'-cap (guanine-N7-)-methyltransferase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID |
|---|
Frequently Asked Questions About mRNA 5'-cap (guanine-N7-)-methyltransferase activity
What is mRNA 5'-cap (guanine-N7-)-methyltransferase activity?
It is the enzymatic activity that adds a methyl group to the N7 position of the guanine cap on mRNA, forming m7G(5')pppR-RNA. This activity is encoded by GO:0004482 and is essential for mRNA stability and translation.
What genes are involved in mRNA 5'-cap (guanine-N7-)-methyltransferase activity?
Key genes include human RNMT and its regulatory subunit RAM, yeast ABD1, and viral genes such as West Nile virus NS5 and coronavirus nsp14.
Why is mRNA cap guanine-N7 methylation important?
It protects mRNA from degradation, facilitates nuclear export, and promotes translation initiation. It also helps viruses evade the host immune system.
How is mRNA 5'-cap (guanine-N7-)-methyltransferase activity measured?
It can be measured using high-throughput screening assays, biochemical assays with purified enzymes, or yeast-based assays for viral enzymes.
What diseases are associated with defects in mRNA cap methylation?
Dysregulation is linked to cancer, viral infections, and parasitic diseases. Viral methyltransferases are targets for antiviral drugs.
Can CRISPR be used to study mRNA 5'-cap (guanine-N7-)-methyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study the function of the enzyme and its role in disease.
What is the role of RNMT in cancer?
RNMT is essential for cell proliferation, and its overexpression can promote oncogenic transformation. Inhibitors of RNMT are being explored as anticancer agents.
How do viruses use guanine-N7 methyltransferases?
Viruses like West Nile virus and coronaviruses encode their own methyltransferases to cap viral RNA, mimicking host mRNA to avoid detection by the immune system.
What is the substrate of mRNA 5'-cap (guanine-N7-)-methyltransferase?
The substrates are S-adenosyl-L-methionine (SAM) and G(5')pppR-RNA. The products are S-adenosyl-L-homocysteine and m7G(5')pppR-RNA.
Are there inhibitors of mRNA cap guanine-N7 methyltransferase?
Yes, high-throughput screening has identified small-molecule inhibitors, particularly for viral enzymes. These are being developed as antiviral and anticancer therapies.
Conclusion
mRNA 5'-cap (guanine-N7-)-methyltransferase activity (GO:0004482) is a fundamental enzymatic function that ensures proper mRNA processing and gene expression in eukaryotes. Its conservation from yeast to humans and its essential role in cell viability highlight its biological importance. The activity is also exploited by viruses to evade host immunity, making it a prime target for antiviral drug development. Furthermore, dysregulation of cap methylation is implicated in cancer and other diseases, offering opportunities for therapeutic intervention. Researchers can leverage CRISPR-based models and high-throughput screening to further dissect the mechanism and regulation of this activity. EDITGENE provides comprehensive services to support such studies, from knockout and point mutation models to library screening and bioinformatics.
References
- 1. Kasprzyk R et al.. 2020. Direct High-Throughput Screening Assay for mRNA Cap Guanine-N7 Methyltransferase Activity.. Chemistry 26(49):11266-11275 PMID: 32259329
- 2. Reichert D et al.. 2021. Computational design and experimental characterization of a photo-controlled mRNA-cap guanine-N7 methyltransferase.. RSC Chem Biol 2(5):1484-1490 PMID: 34704053
- 3. Yamada-Okabe T et al.. 1999. The Candida albicans gene for mRNA 5-cap methyltransferase: identification of additional residues essential for catalysis.. Microbiology (Reading) 145 ( Pt 11):3023-3033 PMID: 10589710
- 4. Sun Y et al.. 2014. Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase.. Antiviral Res 104:156-64 PMID: 24530452
- 5. Ignatochkina AV et al.. 2024. Trypanosome mRNA recapping is triggered by hypermethylation originating from cap 4.. Nucleic Acids Res 52(17):10645-10653 PMID: 39011881
- 6. Mao X et al.. 1995. Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an essential gene.. Mol Cell Biol 15(8):4167-74 PMID: 7623811
- 7. Wang Z et al.. 2026. The EP424R protein of African swine fever virus functions as a 2'-O-methyltransferase and plays an important role in viral replication.. mBio 17(4):e0278625 PMID: 41789918
- 8. Ray D et al.. 2006. West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5.. J Virol 80(17):8362-70 PMID: 16912287
